Collagen's role in skin cancer

October 23, 2015, Queen Mary, University of London
Collagen’s role in skin cancer
Credit: Kome (Flickr)

Type VII collagen is an important protein that helps hold the skin together. Patients with a severe skin condition known as recessive dystrophic epidermolysis bullosa (RDEB) have genetic mutations that lead to reductions in type VII collagen, causing blistering following minor trauma.

Young adults with RDEB go on to develop aggressive, , a type of cancer which is fatal in two thirds by the age of 45.

The study, published in the Journal of the National Cancer Institute, now shows that in both RDEB scarred skin and RDEB tumours, type VII collagen is an important regulator of blood vessel formation – a major mechanism in tumour development.

This study is important for patients with RDEB as it suggests that using non-mutated type VII collagen as a treatment may reverse formation, and potentially prevent tumour development.

Lead researcher Professor Edel O'Toole from the Blizard Institute at QMUL said: "In addition to the potential benefits for RDEB patients, we now know that type VII collagen may play an important role in suppressing tumour formation in skin. This may also be relevant in other organs where type VII collagen is present, such as bowel and oral mucosa."

The researchers grew skin cancer cells in the lab and engineered them to have a loss of type VII collagen. They then built 3D cellular models from human squamous cell carcinoma cells and observed the number of blood vessels that developed.

The team found that that loss of type VII collagen in cell lines and tumours from patients led to increased . Their findings were then confirmed in skin tumours from RDEB patients and the general population.

Explore further: Quality control for adult stem cell treatment

More information: V. L. Martins et al. Suppression of TGF and Angiogenesis by Type VII Collagen in Cutaneous SCC , Journal of the National Cancer Institute (2015). DOI: 10.1093/jnci/djv293

Related Stories

Quality control for adult stem cell treatment

February 27, 2015
A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected ...

Stem cell therapy for inherited skin blistering

May 26, 2015
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was ...

Fractional, ablative er:YAG laser akin for skin resurfacing

November 10, 2012
(HealthDay)—Multiple sessions of fractional laser treatment with erbium:yttrium-aluminum-garnet (Er:YAG) for facial resurfacing are comparable to a single ablative Er:YAG laser treatment, according to a small study published ...

Recommended for you

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

Understanding epilepsy in pediatric tumors

September 20, 2018
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain cancer has not been elucidated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.